glp 1 and ckd Glucagon-like peptide-1 receptor agonists in diabetic kidney disease: A review of their kidney heart protection GLP-1 receptor agonists in patients
Description
That does not mean the treatment has failed for one of them
doi: 10.1016/j.jacl.2023.10.011
Toxic microbiome and progression of chronic kidney disease: insights from a longitudinal CKD-microbiome study
The study included adults aged 18 and older with Type 2 diabetes and/or a body mass index (BMI) above 27
doi: 10.1210/en.2018-00336 [DOI] [PubMed] [Google Scholar] 53.Hiromura M, Mori Y, Kohashi K, et al
